CCL25 Signaling in the Tumor Microenvironment
- 22 July 2021
- book chapter
- research article
- Published by Springer Science and Business Media LLC
- Vol. 1302, 99-111
- https://doi.org/10.1007/978-3-030-62658-7_8
Abstract
Multiple checkpoint mechanisms are overridden by cancer cells in order to develop into a tumor. Neoplastic cells, while constantly changing during the course of cancer progression, also craft their surroundings to meet their growing needs. This crafting involves changing cell surface receptors, affecting response to extracellular signals and secretion of signals that affect the nearby cells and extracellular matrix architecture. This chapter briefly comprehends the non-cancer cells facilitating the cancer growth and elaborates on the notable role of the CCR9-CCL25 chemokine axis in shaping the tumor microenvironment (TME), directly and via immune cells. Association of increased CCR9 and CCL25 levels in various tumors has demonstrated the significance of this axis as a tool commonly used by cancer to flourish. It is involved in attracting immune cells in the tumor and determining their fate via various direct and indirect mechanisms and, leaning the TME toward immunosuppressive state. Besides, elevated CCR9-CCL25 signaling allows survival and rapid proliferation of cancer cells in an otherwise repressive environment. It modulates the intra- and extracellular protein matrix to instigate tumor dissemination and creates a supportive metastatic niche at the secondary sites. Lastly, this chapter abridges the latest research efforts and challenges in using the CCR9-CCL25 axis as a cancer-specific target.Keywords
This publication has 131 references indexed in Scilit:
- Vascular Endothelial Growth Factor Induces CXCL1 Chemokine Release via JNK and PI-3K-Dependent Pathways in Human Lung Carcinoma Epithelial CellsInternational Journal of Molecular Sciences, 2013
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progressionTrends in Immunology, 2010
- Role of CXCR4/SDF-1α in the migratory phenotype of hepatoma cells that have undergone epithelial–mesenchymal transition in response to the transforming growth factor-βCellular Signalling, 2009
- Inverse relationship between dendritic cell CCR9 expression and maturation stateImmunology, 2009
- CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host diseaseNature Immunology, 2008
- Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cellsImmunological Reviews, 2008
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007
- Tumour‐associated macrophages and melanoma tumourigenesis: integrating the complexityInternational Journal of Experimental Pathology, 2006
- A multistep adhesion cascade for lymphoid progenitor cell homing to the thymusProceedings of the National Academy of Sciences of the United States of America, 2006
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006